Professor Robert Glen

Chair in Computational Medicine at Imperial College London and Professor of Molecular Sciences Informatics and Director of The Centre for Molecular Informatics and University of Cambridge. Professor Glen designed the GASP and GOLD computer programs (a BBSRC funded grant he held whilst at the Wellcome Foundation, which has over 4000 citations) which are used extensively in the pharmaceutical industry, he is a co-inventor of Zomig (a drug for migraine with ca. £5 B in sales) and invented two other compounds that have entered Phase-2 clinical development. In 1999 he moved to the University of Cambridge as Director of the Unilever Centre, which he has built to over fifty research scientists. He has published over 150 papers and has a number of compounds currently in human clinical studies through clinical collaboration with Addenbrook’s hospital. Prof Glen is a fellow of the Royal Society of Chemistry and a member of the publication board and chair of the IT committee, an honorary fellow of the American Association for Cancer Research and a Fellow of Clare College Cambridge.

Personal web page